Nutritional Basis for Colonization Resistance by Human Commensal Escherichia coli Strains HS and Nissle 1917 against E. coli O157:H7 in the Mouse Intestine
暂无分享,去创建一个
Paul S. Cohen | T. Conway | Tyrrell Conway | P. Cohen | Rosalie Maltby | Mary P. Leatham-Jensen | Terri Gibson | Rosalie Maltby | Mary Leatham-Jensen | T. Gibson | M. Leatham-Jensen
[1] R. Knabb,et al. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES , 2014, Annals of the New York Academy of Sciences.
[2] D. Swallow,et al. Population Genetics of Lactase Persistence and Lactose Intolerance , 2012 .
[3] J. Frimodt-Møller,et al. The Streptomycin-Treated Mouse Intestine Selects Escherichia coli envZ Missense Mutants That Interact with Dense and Diverse Intestinal Microbiota , 2012, Infection and Immunity.
[4] W. Engst,et al. Dextran Sodium Sulfate-Induced Inflammation Alters the Expression of Proteins by Intestinal Escherichia coli Strains in a Gnotobiotic Mouse Model , 2011, Applied and Environmental Microbiology.
[5] Fatema Z. Chowdhury,et al. Anaerobic Respiration of Escherichia coli in the Mouse Intestine , 2011, Infection and Immunity.
[6] Wolf-Dietrich Hardt,et al. Mechanisms controlling pathogen colonization of the gut. , 2011, Current opinion in microbiology.
[7] C. Josenhans,et al. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models , 2010, Nature Reviews Microbiology.
[8] U. Dobrindt,et al. Safety of Probiotic Escherichia coli Strain Nissle 1917 Depends on Intestinal Microbiota and Adaptive Immunity of the Host , 2010, Infection and Immunity.
[9] Bernard Henrissat,et al. Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins , 2010, Proceedings of the National Academy of Sciences.
[10] R. Xavier,et al. Crohn's disease‐associated adherent‐invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly , 2010, Cellular microbiology.
[11] J. Plumbridge. An Alternative Route for Recycling of N-Acetylglucosamine from Peptidoglycan Involves the N-Acetylglucosamine Phosphotransferase System in Escherichia coli , 2009, Journal of bacteriology.
[12] Paul S. Cohen,et al. Precolonized Human Commensal Escherichia coli Strains Serve as a Barrier to E. coli O157:H7 Growth in the Streptomycin-Treated Mouse Intestine , 2009, Infection and Immunity.
[13] T. Venkatesan. Probiotic Prophylaxis in Predicted Severe Acute Pancreatitis: A Randomised, Double-Blind, Placebo-Controlled Trial. , 2008, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[14] P. Gajer,et al. The Pangenome Structure of Escherichia coli: Comparative Genomic Analysis of E. coli Commensal and Pathogenic Isolates , 2008, Journal of bacteriology.
[15] I. Bjarnason,et al. Probiotic prophylaxis in predicted severe acute pancreatitis , 2008, The Lancet.
[16] Michael Schultz,et al. Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. , 2008, Inflammatory Bowel Diseases.
[17] Fatema Z. Chowdhury,et al. Glycogen and Maltose Utilization by Escherichia coli O157:H7 in the Mouse Intestine , 2008, Infection and Immunity.
[18] Wolf-Dietrich Hardt,et al. The role of microbiota in infectious disease. , 2008, Trends in microbiology.
[19] Paul S. Cohen,et al. Comparison of Carbon Nutrition for Pathogenic and Commensal Escherichia coli Strains in the Mouse Intestine , 2008, Infection and Immunity.
[20] N. Pace,et al. Gastrointestinal microbiology enters the metagenomics era , 2008, Current opinion in gastroenterology.
[21] F. Gunzer,et al. Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background , 2007, International journal of experimental pathology.
[22] J. Strathern,et al. Genetics of Lactase Persistence and Lactose Intolerance , 2008 .
[23] N. Pace,et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.
[24] T. Conway,et al. l-Fucose Stimulates Utilization of d-Ribose by Escherichia coli MG1655 ΔfucAO and E. coli Nissle 1917 ΔfucAO Mutants in the Mouse Intestine and in M9 Minimal Medium , 2007, Infection and Immunity.
[25] Paul S. Cohen,et al. Respiration of Escherichia coli in the Mouse Intestine , 2007, Infection and Immunity.
[26] Daniel B. DiGiulio,et al. Development of the Human Infant Intestinal Microbiota , 2007, PLoS biology.
[27] M. Schmidt,et al. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO‐2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair , 2007, Cellular microbiology.
[28] P. Mannon,et al. The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.
[29] D. Ledoux,et al. Lactobacillus acidophilus bacteraemia after use of a probiotic in a patient with AIDS and Hodgkin's disease , 2006, International journal of STD & AIDS.
[30] R. Welch,et al. Regulation of Type 1 Fimbriae by Unlinked FimB- and FimE-Like Recombinases in Uropathogenic Escherichia coli Strain CFT073 , 2006, Infection and Immunity.
[31] Traci Haddock,et al. Mouse Intestine Selects Nonmotile flhDC Mutants of Escherichia coli MG1655 with Increased Colonizing Ability and Better Utilization of Carbon Sources , 2005, Infection and Immunity.
[32] M. Stolte,et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine , 2004, Gut.
[33] Laurent Beaugerie,et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.
[34] Joe E Grissom,et al. Carbon nutrition of Escherichia coli in the mouse intestine. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[35] Dong-Eun Chang,et al. Glycolytic and Gluconeogenic Growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the Mouse Intestine , 2004, Infection and Immunity.
[36] K. Murphy,et al. Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli , 2003, BMC Molecular Biology.
[37] B. Wanner,et al. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] B. Rembacken,et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial , 1999, The Lancet.
[39] R. Mackie,et al. Developmental microbial ecology of the neonatal gastrointestinal tract. , 1999, The American journal of clinical nutrition.
[40] T. Conway,et al. What’s for Dinner?: Entner-Doudoroff Metabolism inEscherichia coli , 1998, Journal of bacteriology.
[41] M. Levine,et al. Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers. , 1995, The Journal of infectious diseases.
[42] G R Jacobson,et al. Phosphoenolpyruvate:carbohydrate phosphotransferase systems of bacteria. , 1993, Microbiological reviews.
[43] D. van der Waaij,et al. Determination of colonization resistance of the digestive tract by biotyping of Enterobacteriaceae , 1990, Epidemiology and Infection.
[44] A. Rimm,et al. Transplant or chemotherapy in acute myelogenous leukaemia , 1989 .
[45] R. Simmons,et al. Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria , 1987, Infection and immunity.
[46] R. Freter,et al. Models for studying the role of bacterial attachment in virulence and pathogenesis. , 1983, Reviews of infectious diseases.
[47] R. Freter,et al. Continuous-flow cultures as in vitro models of the ecology of large intestinal flora , 1983, Infection and immunity.
[48] R. Freter,et al. Survival and Implantation of Escherichia coli in the Intestinal Tract , 1983, Infection and immunity.
[49] R. Freter,et al. Mechanisms That Control Bacterial Populations in Continuous-Flow Culture Models of Mouse Large Intestinal Flora , 1983, Infection and immunity.
[50] R. Freter,et al. Experimental and Mathematical Models of Escherichia coli Plasmid Transfer In Vitro and In Vivo , 1983, Infection and immunity.
[51] D. Tilman. Resource competition and community structure. , 1983, Monographs in population biology.
[52] M. Levine,et al. Failure to detect conventional enterotoxins in classical enteropathogenic (serotyped) Escherichia coli strains of proven pathogenicity , 1982, Infection and immunity.
[53] Daniel S Waterman,et al. ESCHERICHIA COLI STRAINS THAT CAUSE DIARRHŒA BUT DO NOT PRODUCE HEAT-LABILE OR HEAT-STABLE ENTEROTOXINS AND ARE NON-INVASIVE , 1978, The Lancet.
[54] F. Neidhardt,et al. Culture Medium for Enterobacteria , 1974, Journal of bacteriology.
[55] H. Dupont,et al. EXPERIMENTAL MODELS IN THE INVESTIGATION OF THE VIRULENCE OF DYSENTERY BACILLI AND ESCHERICHIA COLI * , 1971 .
[56] S. Formal,et al. EXPERIMENTAL SHIGELLA INFECTIONS: CHARACTERISTICS OF A FATAL INFECTION PRODUCED IN GUINEA PIGS , 1958, Journal of bacteriology.
[57] L. S. Clark,et al. The effect of streptomycin on oxygen uptake and viability of resting suspensions of Escherichia coli. , 1953, Science.
[58] I. L. Barkulis. INHIBITION OF THE ANAEROBIC PYRUVATE METABOLISM OF ESCHERICHIA COLI BY DIHYDROSTREPTOMYCIN, , , 1953, Journal of bacteriology.
[59] A. Nissle. [Mutaflor and its medical significance]. , 1951, Zeitschrift fur klinische Medizin.
[60] R. J. Henry,et al. The effect of streptomycin on the metabolism of multiplying bacteria. , 1949, Journal of bacteriology.
[61] W. Umbreit. A site of action of streptomycin. , 1949, The Journal of biological chemistry.